Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2009
10/14/2009EP2107906A2 Novel therapeutic use for treating leukaemia
10/14/2009EP1732569B1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
10/14/2009EP1554572B1 Compositions and methods for modulating blood-brain barrier transport
10/14/2009EP1474158B1 Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1360498B1 Latent human tuberculosis diagnostic antigen and method of use
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1292325B1 Matrix protein compositions for dentin regeneration
10/14/2009EP1180686B1 Remedies for kidney diseases and method for screening the same
10/14/2009EP1139793B1 Inhibitors of the bitter taste response
10/14/2009CN101557826A Therapeutic agent for urinary tract disease
10/14/2009CN101557811A Use of dipeptidyl peptidase IV inhibitors for preventing, delaying or reducing the occurance of edema
10/14/2009CN101557806A Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases
10/14/2009CN101555283A Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
10/14/2009CN101554479A Pharmaceutical composition containing an iron-binding agent
10/14/2009CN100548993C Salts of valsartan
10/14/2009CN100548977C Prostaglandin-like compound and its uses for treatment of external secretion disorders
10/14/2009CN100548383C Method and compositions for prevention or treatment of cancer
10/14/2009CN100548381C Bitterness-masking particulate jelly beverage
10/14/2009CN100548380C Long-acting sustained-release medicaments for treating and renovating osteomyelitis and preparation thereof
10/14/2009CN100548377C Vaccine composition containing modified dendritic cells
10/14/2009CN100548376C Organic selenium from aspergillus oryzae and method for preparing same
10/14/2009CN100548375C Antitumor effect potentiators
10/14/2009CN100548291C MCH antagonists for the treatment of obesity
10/14/2009CN100548288C Memory fixation accelerator
10/14/2009CN100548283C Prevention and treatment of androgen-deprivation induced osteoporosis
10/14/2009CN100548279C Delayed total release gastrointestinal drug delivery system
10/14/2009CN100548277C Preparing method of powder agglomerates
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
10/13/2009US7601814 Reduce binding to epitope to fusion protein; reduce its ability to interact with a T cell receptor; use in immunotherapy
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601740 urea substituted piperidine derivatives; may confer antipsychotic and anti-dyskinetic efficacy in humans; use as novel therapeutics, sometimes in conjunction with other therapeutics, for Parkinson's Disease, related human neurodegenerative diseases, and psychosis
10/13/2009US7601735 Antiviral compounds
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601720 especially dimethylphenylpiperazinium; treating a variety of pulmonary diseases with fewer side effects than other anti-inflammatory drugs, such as steroids
10/13/2009US7601705 Polymer controlled induced viscosity fiber system and uses thereof
10/13/2009US7601703 Complexing the target cell with therapeutic agent; antiproliferative agent
10/13/2009US7601525 Alginate gel scaffold having a plurality of continuous parallel microtubular copper capillaries
10/13/2009US7601369 Composition and method to augment and sustain neurotransmitter production
10/13/2009US7601360 Excitatory amino acid inhibitors for treating sensitive skins
10/13/2009US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/13/2009US7601347 Methods and compositions for controlled release of bioactive compounds
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009US7601157 Devices and methods for the restoration of a spinal disc
10/13/2009CA2602188C Dosage forms of risedronate
10/13/2009CA2521846C Reverse-turn mimetics and method relating thereto
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2470484C A combination comprising combretastatin and anticancer agents
10/13/2009CA2455246C Drug preparation comprising .alpha.-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ace) and its use for the treatment of neurodegenerative diseases
10/13/2009CA2449572C 4'-substituted nucleosides
10/13/2009CA2447807C Abuse resistant pharmaceutical composition containing capsaicin
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/13/2009CA2428160C Compositions for antitumor treatment containing ecteinascidin 743
10/13/2009CA2414665C Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
10/13/2009CA2396093C Process and composition for controlling fecal hair excretion and trichobezoar formation
10/13/2009CA2379666C Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof
10/13/2009CA2356331C Methods for glucagon suppression
10/13/2009CA2321265C Antibacterial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith
10/13/2009CA2224413C Immunovectors for the intracellular and intranuclear transport
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/13/2009CA2154488C Ganglioside-klh conjugate vaccines with qs-21
10/08/2009WO2009124103A2 Combination therapies comprising par1 antagonists with par4 antagonists
10/08/2009WO2009123742A1 Use of ribose in first response to acute myocardial infarction
10/08/2009WO2009123457A2 Compositions and methods for treating sweet itch
10/08/2009WO2009123364A1 Mineral absorption accelerator and iron deficiency anemia improver or food composition
10/08/2009WO2009123215A1 Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method
10/08/2009WO2009123145A1 Parasporin-1 receptor and use thereof
10/08/2009WO2009122667A1 Therapeutic for hepatic cancer
10/08/2009WO2009122639A1 Abc transporter protein expression inhibitor
10/08/2009WO2009121945A2 New formulations, tablets comprising such formulations, their use and process for their preparation
10/08/2009WO2009121687A1 L-citrulline for treating endothelial dysfunction and erectile dysfunction
10/08/2009WO2009121238A1 A composition and method for auto-treating tumors
10/08/2009WO2009102962A3 Combination of alpha 7 nicotinic agonists and antipsychotics
10/08/2009WO2009102467A3 Devices, formulations, and methods for delivery of multiple beneficial agents
10/08/2009WO2009027056A4 Antioxidant and paramagnetic heparin-nitroxide derivatives
10/08/2009WO2008118552A9 Use of ranolazine for the treatment of cardiovascular diseases
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090254021 Kit for administering a therapeutic agent into tissue
10/08/2009US20090253795 Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibiton of pain and inflammation
10/08/2009US20090253698 Brain, Spinal and Nerve Injury Treatment
10/08/2009US20090253685 Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent
10/08/2009US20090253675 Pharmaceutical formulation
10/08/2009US20090253665 Method of treatment of disease using an adenosine a1 receptor antagonist and an aldosterone inhibitor
10/08/2009US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009US20090252721 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
10/08/2009US20090252712 Chimeric c3-like rho antagonist bone therapeutic
10/08/2009CA2757442A1 Use of ribose in first response to acute myocardial infarction
10/08/2009CA2720450A1 New formulations, tablets comprising such formulations, their use and process for their preparation
10/08/2009CA2720359A1 Liver cancer drug
10/08/2009CA2714996A1 Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
10/07/2009EP2107109A1 Recombinant vascular endothelial cell growth factor D (VEGF-D)
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106795A1 Use of phthalide dipolymers for antitumor
10/07/2009EP2106794A1 Ubiquitin alone or in combination for use in the treatment of sweet itch.
10/07/2009EP2032596B1 Neuroprotective compounds and uses thereof
1 ... 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 ... 1151